...
首页> 外文期刊>The European respiratory journal : >Sputum colour and bacteria in chronic bronchitis exacerbations: A pooled analysis
【24h】

Sputum colour and bacteria in chronic bronchitis exacerbations: A pooled analysis

机译:慢性支气管炎加重时痰液颜色和细菌的汇总分析

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We examined the correlation between sputum colour and the presence of potentially pathogenic bacteria in acute exacerbations of chronic bronchitis (AECBs). Data were pooled from six multicentre studies comparing moxifloxacin with other antimicrobials in patients with an AECB. Sputum was collected before antimicrobial therapy, and bacteria were identified by culture and Gram staining. Association between sputum colour and bacteria was determined using logistic regression. Of 4,089 sputum samples, a colour was reported in 4,003; 1,898 (46.4%) were culture-positive. Green or yellow sputum samples were most likely to yield bacteria (58.9% and 45.5% of samples, respectively), compared with 18% of clear and 39% of rust-coloured samples positive for potentially pathogenic microorganisms. Factors predicting a positive culture were sputum colour (the strongest predictor), sputum purulence, increased dyspnoea, male sex and absence of fever. Green or yellow versus white sputum colour was associated with a sensitivity of 94.7% and a specificity of 15% for the presence of bacteria. Sputum colour, particularly green and yellow, was a stronger predictor of potentially pathogenic bacteria than sputum purulence and increased dyspnoea in AECB patients. However, it does not necessarily predict the need for antibiotic treatment in all patients with AECB.
机译:我们检查了痰颜色与慢性支气管炎(AECBs)急性加重中潜在病原菌的存在之间的相关性。收集了来自六个多中心研究的数据,这些研究比较了莫西沙星与其他抗菌素对AECB患者的影响。在进行抗菌治疗之前收集痰液,并通过培养和革兰氏染色鉴定细菌。痰液颜色和细菌之间的关联使用逻辑回归确定。在4,089份痰标本中,有4,003份报告了颜色。 1,898(46.4%)为培养阳性。绿色或黄色的痰液样本最有可能产生细菌(分别为样本的58.9%和45.5%),相比之下,对于潜在病原微生物呈阳性的清澈样本和锈色样本为18%。预测培养阳性的因素是痰液颜色(最强的预测因子),痰液化脓,呼吸困难增加,男性和不发烧。绿色或黄色与白色的痰液颜色相关,细菌存在的敏感性为94.7%,特异性为15%。痰液的颜色,尤其是绿色和黄色,比潜在的病原菌更能预测痰液的脓性和呼吸困难,而这是AECB患者的症状。但是,它不一定能预测所有AECB患者是否需要抗生素治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号